Related Articles

• 
  FDA Issues Final Guidances on Postmarket Surveillance and Post-approval Studies

  The two new final guidances are intended to increase transparency to stakeholders on the FDA’s approach to the issuance and tracking of 522 orders and post-approval study requirements.

• 
  FDA Resumes Domestic Surveillance Inspections

  Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.

• 
  FDA Updates Breakthrough Devices Guidance Focused on Health Equity

  The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…

• 
  FDA CDRH Announces Reopening for All IVD Pre-Submissions

  As of June 1, 2022, the Center for Devices and Radiological Health plans to accept all non-COVID in vitro diagnostic (IVD) pre-submissions.